Close

Needham & Company Maintains a 'Hold' on Impax Laboratories (IPXL); Adderall XR Supply Issue Rears its Ugly Head but OpEx Leverage Still Allows 3Q11 EPS to Beat Nov 2, 2011 08:04AM
Notable Analyst Rating Changes 06/08: (BOBE) (EBAY) (VZ) Upgraded; (IPXL) (QNST) (SPWRA) Downgraded Jun 8, 2011 11:05AM
Needham & Company Maintains a 'Hold' on Warner Chilcott (WCRX); Warning Letter Could Complicate “Sweetest” Doryx 150mg Settlement Outcomes Jun 7, 2011 07:41AM
Needham & Company Maintains a 'Hold' on Impax Laboratories (IPXL); FDA Warning Letter Puts The Brakes On New Approvals For Now Though We See Little Lasting Impact Jun 7, 2011 07:30AM
Notable 52-Week Highs and Lows of the Day 03/15: (IPXL) (PAY) (WSM) High; (NOK) (AOB) (GM) Low Mar 15, 2011 03:08PM


Mar 15, 2011 08:13AM Needham & Company Maintains a 'Hold' on Impax Laboratories (IPXL); Branded Platform Still Remains A “Show-Me” Story
Nov 30, 2010 01:28PM Needham & Company on Impax Labs (IPXL); Lawsuit Appears to Confirm That Generic Concerta Opportunity Remains A Real But Distant Star On Horizon
Jul 13, 2010 07:29AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Receives Final Approval for Generic Oracea Potentially Setting Up Exclusivity Launch
Mar 23, 2010 09:03AM Needham & Company Initiates Coverage on Impax Laboratories (IPXL) with a Hold
Mar 23, 2010 08:23AM Needham & Company Initiates Coverage on Impax Laboratories (IPXL) with a Hold
Jan 8, 2010 10:51AM Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded